[Current trends in the treatment of acute myocardial infarct].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001919:Bradycardia / Q000209:etiology / Q000628:therapy; D005947:Glucose / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D007328:Insulin / Q000627:therapeutic use; D008012:Lidocaine / Q000008:administration & dosage; D008353:Mannitol / Q000627:therapeutic use; D008991:Monitoring, Physiologic; D009203:Myocardial Infarction / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D009449:Neurocirculatory Asthenia / Q000209:etiology / Q000628:therapy; D009573:Nitrites / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D011188:Potassium / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D012770:Shock, Cardiogenic / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology
D000305:Adrenal Cortex Hormones; D000925:Anticoagulants; D007328:Insulin; D009573:Nitrites; C030396:glucose-insulin-potassium cardioplegic solution; D008353:Mannitol; D008012:Lidocaine; D011433:Propranolol; D006821:Hyaluronoglucosaminidase; D005947:Glucose; D011188:Potassium
Orientări actuale în tratamentul infarctului miocardic acut.